Skyepharma is a specialized contract development and manufacturing organization (CDMO) with expertise in formulating, synthesizing, and manufacturing intricate oral dosage forms, including custom modified release profiles. Our comprehensive services encompass early-stage development through to industrial production and packaging. Supported by our patented technologies, our team of scientific experts has a proven track record in successful development, reformulation, and transfer projects. Our GMP-certified facility in France, which is approved by the FDA, caters to a global clientele and is renowned for delivering high-quality services.